minimizes receptor desensitization Extended Regeneration Protocol Dose: 0.5 + 0.5 mg (variant 5 + 5 mg pen = 20 clicks / variant 5 + 10 mg pen = 13 clicks) Duration: 12 16 weeks Frequency: 1 daily Cycle Interval: 8-week rest Goal / Description: Long-term tissue recovery, collagen stimulation, and fat metabolism support Possible Side Effects CJC-1295 (No-DAC) and Ipamorelin are generally observed to be well-tolerated in research, particularly Ipamorelin due to its selectivity in not raising cortisol or prolactin levels
In fact, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies due to insufficient safety evidence in humans
Half the peptide means roughly half the price, making initial experimentation more accessible
This approach demonstrated high feasibility for early in vivo diagnosis of ACI/AKI, detecting these conditions at least 24 and 48 hours earlier than standard clinical assays for ACI and AKI, respectively
Therefore, use it as directed by your doctor even if you are healthy